General Information of the Compound
| Compound ID |
CP0095776
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Benzenesulfonylamino-N-hydroxy-benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-(Phenylsulfonylamino)benzohydroximic acid
4-Benzenesulfonylamino-N-hydroxy-benzamide
BDBM50105682
CHEMBL98345
N-hydroxy-4-(phenylsulfonamido)benzamide
SCHEMBL15480538
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H12N2O4S
|
||||||||||||||||||
| Molecular Weight |
292.316
|
||||||||||||||||||
| Canonical SMILES |
ONC(=O)c1ccc(NS(=O)(=O)c2ccccc2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H12N2O4S/c16-13(14-17)10-6-8-11(9-7-10)15-20(18,19)12-4-2-1-3-5-12/h1-9,15,17H,(H,14,16)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZSIKBIFOAPITGF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000067 | HCT 116 | Homo sapiens (Human) | 1 |
| 1 |
EC50 = 2000 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|
Clinical Information about the Compound